# Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant

> **NCT01852591** · NA · COMPLETED · sponsor: **H. Lee Moffitt Cancer Center and Research Institute** · enrollment: 8 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** PCV 13

## Key facts

- **NCT ID:** NCT01852591
- **Lead sponsor:** H. Lee Moffitt Cancer Center and Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2015-02
- **Final completion:** 2016-10
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01852591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01852591, "Exploration of Immune Response to Early PCV13 Vaccination in Conjunction With Autologous Transplant". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01852591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*